menopausal symptoms

Menopause: New Insight Into Hot Flashes and Night Sweats

6616 views

Menopause is defined as the time after a woman’s final menstrual period, and is confirmed after one year with no periods. For many women, this is a natural, gradual process, that begins with perimenopause: the four to eight years before the final period. The time through perimenopause, the final menstrual period, and a few years after the final period is known as the menopausal transition. Many women go through this transition naturally as they age, but other women go through induced menopause, caused by surgical removal of the ovaries or cancer treatments.

Symptoms Related to Menopause

The average age of menopause in North America is 51 years, with most women going through menopause between the age of 40 and 58. During the menopausal transition, hormonal changes may result in symptoms that range from mildly bothersome to downright unbearable. Vasomotor symptoms, or hot flashes and night sweats, are one of the main menopause-related symptoms that women seek medical treatment for, and are experienced by about 80% of women during the menopausal transition. Some women also experience vaginal dryness and/or pain with sexual intercourse during menopause.

During perimenopause, many women will start to experience hot flashes and night sweats. Other symptoms of perimenopause include vaginal dryness, irregular periods, sleep problems, mood changes, weight gain, thinning hair, and dry skin (sounds awesome, right?). However, the North American Menopause Society correctly points out that the menopausal transition often coincides with a number of midlife stressors such as relationship issues/divorce, caring for aging parents, career issues, and struggles with adolescents (is anyone else’s hair going grey from teenage daughter stress?). These stressors may also contribute to symptoms a woman experiences at this time.

Hot flashes and night sweats (vasomotor symptoms or VMS) can be troublesome to many women. As with other issues in women’s health, lack of research led to the long held false assumption that these symptoms are generally experienced for only a few years right around the final menstrual period. However, new research has shown that in some women, these symptoms last for a decade or longer. In addition, the pattern of these symptoms, or when they occur relative to the final menstrual period, is not the same in all women.

New Insights into Frequency and Timing of Hot Flashes and Night Sweats

A recent, large study of ethnically diverse women going through natural menopause across the U.S. has provided some new insights into how women experience vasomotor symptoms during menopause and who is at risk for longer lasting or more severe symptoms. This study followed women from 12 years before the final menstrual period to 15 years after. The median duration of vasomotor symptoms was 7.4 years and the median persistence of symptoms after the final period was 4.5 years. In this study, frequent vasomotor symptoms lasting more than seven years occurred in more than 50% of women. Starting to have vasomotor symptoms at a younger age was predictive of having a longer duration of symptoms, and surprisingly, of having a longer persistence of symptoms after the final period.

This study also found that vasomotor symptoms during the menopausal transition fall into four distinct patterns. In about 27% of women, called the early onset, low frequency group, there is a low probability of vasomotor symptoms across the whole menopausal transition, with a slight increase around the time of the final menstrual period. In 26% of women, there was a  high frequency of vasomotor symptoms throughout the entire menopausal transition. In the 18% of women who had an early onset, there was a higher frequency of symptoms, which decreased right after the last period. And 29% of women had a late onset of higher frequency symptoms, with a sharp increase just after the final period.

The study also examined whether certain health or lifestyle measures were associated with particular patterns of vasomotor symptoms and some associations were found. Relative to the women in the low frequency group, women with early onset, higher frequency symptoms were older at the final menstrual period, were in poorer health, and were more likely to suffer from depression and anxiety. Women with late onset, higher frequency symptoms were more likely to be African American/black, more likely to be smokers, and less likely to be obese. And women in the high frequency group were more likely to have less education, be in poorer health, have an increased consumption of alcohol, have depression and anxiety, and be African American/black.

These “co-variables” were all independently associated, meaning, for example, that someone with poor physical health, or depression and anxiety, was more likely in this study to be in the early onset, high frequency group, or in the group with high frequency across the whole transition. The other variables did not need to be present in addition, to create the association.

Hormones Levels During the Menopausal Transition

It has generally been thought that declining estrogen levels during the menopausal transition are responsible for vasomotor and other menopausal symptoms. However, not surprisingly, this view is too simplistic. This same study measured the concentrations of one of the major estrogens in the human body, estradiol, throughout the study, and found that estradiol concentrations have four different patterns during this time as well. However, these patterns did not correlate perfectly with the different groupings of vasomotor symptoms.

In general, women with a consistently lower concentrations of estradiol were more likely to have frequent symptoms across the menopausal transition. However, the study also found that fluctuations in estradiol around the time of the final menstrual period may be associated with vasomotor symptoms at this time. A greater rise in follicle-stimulating hormone (FSH) was also associated with a greater likelihood of vasomotor symptoms. The conclusion of the study was that estradiol alone was not solely responsible for vasomotor symptoms; that other hormones varying during this time may also play a role. For example, some adrenal steroid hormones increase transiently during menopause.  DHEAS, a steroid hormone that generally declines with age,  increases transiently in some women during menopause.

Are Cardiac Risks Related to Vasomotor Symptoms?

After menopause, a women’s risk of certain serious conditions increases, including cardiovascular disease and osteoporosis. Some preliminary results suggest that the pattern of vasomotor symptoms may be correlated to an increased risk for cardiovascular disease. In one study, carotid intima media thickness (IMT) was measured, which can detect the presence of atherosclerotic disease before cardiovascular symptoms appear. Women with early onset vasomotor symptoms had higher IMT compared to women with low frequency of vasomotor symptoms. This could indicate a higher risk of cardiac events for women who fall into this group. In another study, late vasomotor symptoms were found to be associated with an increased risk of major cardiovascular events, stroke, and death from all causes, and this association was not accounted for by other risk factors. However, because of the size of the study, these results are considered preliminary. More research may allow doctors to predict, based on a woman’s pattern of vasomotor symptoms, her risk of cardiac and other serious events, and may allow doctors to direct lifestyle and other early interventions to those most at risk.

Altogether, this research on vasomotor symptoms during the menopausal transition is helpful because it can help women understand what to expect. It may also help guide treatment decisions for women who are seeking treatment for symptoms; for example, if they start having frequent symptoms early, this may be a sign that these symptoms will persist. In addition, if risks for serious health problems are associated with distinct patterns of vasomotor symptoms, again, this information could help guide early interventions, and help women be alert for early warning signs of a problem.

 

Quick News: HRT, Gallstones and Gallbladder Disease

6127 views

Hormone replacement therapy or HRT, used by millions of women worldwide to minimize the severity of menopausal symptoms, is associated with increased risk of gallbladder disease necessitating surgery to remove the gallbladder. A recently published, very large (+70,000 women), longitudinal study assessed the risk for gallstones, gallbladder disease and gallbladder removal in women who used synthetic HRT medications either in patch or oral form.

The researchers found a significant increase in cholecystectomy – the surgical removal of the gallbladder as a result of complications related to gallstones in the women who used synthetic HRTs. The risk was was so high that researchers estimated that over five years, 1 in every 150 women who use HRT would require a surgery.

Over five years, about one cholecystectomy in excess would be expected in every 150 women using oral estrogen therapy without a progestagen, compared with women not exposed to menopausal hormone therapy. 

Dr. Antoine Racine of South Paris University, study author

The study also showed that using oral, estrogen only HRT, as is more common in the US and UK than in France where the study was conducted, poses a greater risk for gallbladder disease than the either oral HRT with a progestogen or the transdermal HRT patch. Indeed, the transdermal and gel HRT formulas showed little increase in expected numbers of cholecystectomy. It should be noted that the increased gallbladder disease is in addition to the already well-documented increases in heart disease, stroke, breast cancer and blood clots. It may be time to reconsider synthetic HRT therapies and look toward more natural treatment options.

Does Maca Powder Reduce Menopausal Symptoms?

3116 views

Every week it seems a new alternative treatment for menopausal symptoms hits the shelves. Recently, the hormonal benefits of Maca powder have been all the rage. Maca is an herb/root organically grown in the Andean Mountains of Peru. It is typically sold in a powdered form and commonly available in health food stores. Dense in nutrition, vitamins and minerals, Maca powder contains approximately 60% carbohydrates, 9% fiber, and 10% protein or higher.

According to Peruvian biologist Gloria Chacon de Popivici, Ph.D., Maca alkaloids act on the hypothalamus-pituitary axis and the adrenals. She has theorized that by activating these endocrine glands, Maca is able to increase energy, vitality and libido. In addition, she claims Maca improves memory and blood oxygenation.

A team of researchers at Victoria University in Australia conducted a double blind, placebo-controlled crossover trial and concluded that while Maca may reduce psychological symptoms, including anxiety and depression, and lower measures of sexual dysfunction in postmenopausal women, these effects appear independent of estrogenic and androgenic activity.

According to their findings:

“No differences were seen in serum concentrations of estradiol, follicle-stimulating hormone, luteinizing hormone, and sex hormone-binding globulin between baseline, Maca treatment, and placebo (P > 0.05). The Greene Climacteric Scale revealed a significant reduction in scores in the areas of psychological symptoms, including the subscales for anxiety and depression and sexual dysfunction after Maca consumption compared with both baseline and placebo (P < 0.05). These findings did not correlate with androgenic or alpha-estrogenic activity present in the Maca as no physiologically significant activity was observed in yeast-based assays employing up to 4 mg/mL Maca extract (equivalent to 200 mg/mL Maca).”

Whether you believe claims that Maca can correct hormone imbalances, or you are simply looking for an all natural supplement that will address your menopausal symptoms, Maca is a nutritious super food that may bring some relief. I’ve begun adding a tablespoon to my morning green smoothies. It adds a nice flavor and has the added benefit of being a great emulsifier. I’ll let you know how it goes.

Searching the internet, however, there are reports of side-effects from Maca (here and here), especially at a high dosage (1500-3000 mg/day).  Before beginning any new supplement regime, consult your physician.

Sources:

Brooks NA, Wilcox G, Walker KZ, Ashton JF, Cox MB, Stojanovska L. Menopause. 2008 Nov-Dec;15(6):1157-62. “Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content.” School of Biomedical and Health Sciences, Victoria University, St. Albans, Victoria, Australia.

Carter, Ronald, M.D.”Clinical Effects of a Proprietary, Standardized, Concentrated, Organic Lepidium Peruvianum Formulation (Maca-GO®) as an Alternative to HRT”

 

 

Lucine Medical Disclaimer: All material on this website is provided for your information only and may not be construed as, nor should it be a substitute for, professional medical advice. To read more about our health policy, see Terms of Use.